ATE246502T1 - Arzneiformen enthaltend carvedilol - Google Patents

Arzneiformen enthaltend carvedilol

Info

Publication number
ATE246502T1
ATE246502T1 AT99916904T AT99916904T ATE246502T1 AT E246502 T1 ATE246502 T1 AT E246502T1 AT 99916904 T AT99916904 T AT 99916904T AT 99916904 T AT99916904 T AT 99916904T AT E246502 T1 ATE246502 T1 AT E246502T1
Authority
AT
Austria
Prior art keywords
forms containing
medicinal forms
containing carvedilol
carvedilol
medicinal
Prior art date
Application number
AT99916904T
Other languages
English (en)
Inventor
Rolf-Dieter Gabel
Walter Preis
Alexander Wirl
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998116036 external-priority patent/DE19816036A1/de
Priority claimed from EP98112241A external-priority patent/EP0968714A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of ATE246502T1 publication Critical patent/ATE246502T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT99916904T 1998-04-09 1999-04-01 Arzneiformen enthaltend carvedilol ATE246502T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998116036 DE19816036A1 (de) 1998-04-09 1998-04-09 Verfahren zur Herstellung schnellauflösender pharmazeutischer Zubereitungen von schwerlöslichen Wirkstoffen
EP98112241A EP0968714A1 (de) 1998-07-02 1998-07-02 Verfahren zur Herstellung schnellauflösender pharmazeutischer Zubereitungen von schwerlöslichen Wirkstoffen
PCT/EP1999/002270 WO1999052526A1 (en) 1998-04-09 1999-04-01 Carvedilol-galenics

Publications (1)

Publication Number Publication Date
ATE246502T1 true ATE246502T1 (de) 2003-08-15

Family

ID=26045401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99916904T ATE246502T1 (de) 1998-04-09 1999-04-01 Arzneiformen enthaltend carvedilol

Country Status (12)

Country Link
EP (1) EP1069896B1 (de)
JP (2) JP3947654B2 (de)
KR (1) KR100520589B1 (de)
CN (1) CN1151788C (de)
AR (1) AR018179A1 (de)
AT (1) ATE246502T1 (de)
AU (1) AU3522399A (de)
CA (1) CA2326840C (de)
DE (1) DE69910188T2 (de)
DK (1) DK1069896T3 (de)
ES (1) ES2204121T3 (de)
WO (1) WO1999052526A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
CN103288714A (zh) 2002-06-27 2013-09-11 史密斯克莱.比奇曼（科克）有限公司 卡维地洛磷酸盐和/或其溶剂合物相应的组合物和/或治疗方法
EP1539140A4 (de) 2002-06-27 2005-12-07 Sb Pharmco Inc Carvedilolhydobromid
US7750036B2 (en) 2003-11-25 2010-07-06 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
CA2547137A1 (en) 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US8367112B2 (en) * 2006-02-28 2013-02-05 Alkermes Pharma Ireland Limited Nanoparticulate carverdilol formulations
US8889728B2 (en) 2008-03-04 2014-11-18 Lupin Limited Stable pharmaceutical compositions of carvedilol
TWI415604B (zh) * 2009-09-29 2013-11-21 Tsh Biopharm Corp Ltd 調控釋放卡菲蒂羅劑型
JP5602936B2 (ja) * 2010-03-29 2014-10-08 フイルメニツヒ ソシエテ アノニム 噴霧乾燥した結晶性活性成分
CN104528744A (zh) * 2015-01-15 2015-04-22 中国药科大学 一种扩孔介孔二氧化硅的简单制备及其促溶应用
KR102158339B1 (ko) 2016-02-05 2020-09-21 삼진제약주식회사 인습성이 개선된 카르베딜롤 속방성 제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH0249720A (ja) * 1988-05-18 1990-02-20 Mitsubishi Kasei Corp 難溶性薬剤組成物
JPH0776516A (ja) * 1993-09-06 1995-03-20 Toyobo Co Ltd 難溶性薬物含有製剤の製造方法
JPH107558A (ja) * 1996-06-19 1998-01-13 Eisai Co Ltd 溶解性改善製剤
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets

Also Published As

Publication number Publication date
AR018179A1 (es) 2001-10-31
CA2326840C (en) 2007-08-07
JP2007145856A (ja) 2007-06-14
KR100520589B1 (ko) 2005-10-10
EP1069896B1 (de) 2003-08-06
WO1999052526A1 (en) 1999-10-21
CA2326840A1 (en) 1999-10-21
DE69910188T2 (de) 2004-06-17
CN1151788C (zh) 2004-06-02
JP2002511413A (ja) 2002-04-16
ES2204121T3 (es) 2004-04-16
CN1295472A (zh) 2001-05-16
KR20010042574A (ko) 2001-05-25
DE69910188D1 (de) 2003-09-11
EP1069896A1 (de) 2001-01-24
JP3947654B2 (ja) 2007-07-25
AU3522399A (en) 1999-11-01
DK1069896T3 (da) 2003-11-17

Similar Documents

Publication Publication Date Title
DE69834019D1 (de) Dose
NO20005913L (no) Legemiddelsammensetning
ID23874A (id) Obat
NO992339L (no) Farmasöytiske formuleringer
ID27841A (id) Turunan-turunan biaril terapeutik
ID29089A (id) Sediaan farmasi moksifloksasin
NO20005179D0 (no) Medikament behandling
DE69935609D1 (de) Formulierungen enthaltend cefuroxim-axetil
DE69902440T2 (de) Rollstuhl
DE69928344D1 (de) Pharmazeutisches Implantat
ATE246502T1 (de) Arzneiformen enthaltend carvedilol
DE59915029D1 (de) Medizinisches gerät
ID30397A (id) Larutan oral prukaloprida
DE29817702U1 (de) Rollstuhl
DE29817592U1 (de) Dose
DE29801440U1 (de) Tabletten-Einnahmehilfe
NO20012476D0 (no) Rullestol
DE29715802U1 (de) Schluckbrunnen
DE29715521U1 (de) Medizinisches Gerät
KR980003246U (ko) 이동식 캡슐화장실
DE29805799U1 (de) Rollstuhl
DE29704339U1 (de) Beruhigungssauger
DE29811342U1 (de) Kapsel
DE29813144U1 (de) Kapsel
DE29821753U1 (de) Dose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1069896

Country of ref document: EP

REN Ceased due to non-payment of the annual fee